).
Identifying very low birth weight (VLBW) infants at increased risk of death and adverse outcomes is important for clinical research, resource allocation, and benchmarking across neonatal intensive care units (NICUs). While demographic and perinatal clinical variables are often used to predict adverse outcomes, physiologic measures of illness severity are likely to improve risk stratification.
1-3
Previously, we developed a risk score in a single-center study using heart rate (HR) characteristics (HRC) in the first day and first week after birth to predict death and multiple short-term adverse outcomes related to prematurity.
1 While the HRC index was developed to predict risk of imminent sepsis, 4 early HRC added information to gestational age (GA) about risk of later sepsis as well as death, severe IVH and bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age (PMA). We then showed, in a two-center study, that adding oxygen saturation (SpO 2 ) analysis to HRC improved algorithms for predicting imminent sepsis and necrotizing
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Abstract
Background We previously showed, in a single-center study, that early heart rate (HR) characteristics predicted later adverse outcomes in very low birth weight (VLBW) infants. We sought to improve predictive models by adding oxygenation data and testing in a second neonatal intensive care unit (NICU). Methods HR and oxygen saturation (SpO 2 ) from the first 12 hours and first 7 days after birth were analyzed for 778 VLBW infants at two NICUs. Using multivariate logistic regression, clinical predictive scores were developed for death, severe intraventricular hemorrhage (sIVH), bronchopulmonary dysplasia (BPD), treated retinopathy of prematurity (tROP), late-onset septicemia (LOS), and necrotizing enterocolitis (NEC). Ten HR-SpO 2 measures were analyzed, with first 12 hours data used for predicting death or sIVH and first 7 days for the other outcomes. HR-SpO 2 models were combined with clinical models to develop a pulse oximetry predictive score (POPS). Net reclassification improvement (NRI) compared performance of POPS with the clinical predictive score. Results Models using clinical or pulse oximetry variables alone performed well for each outcome. POPS performed better than clinical variables for predicting death, sIVH, and BPD (NRI > 0.5, p < 0.01), but not tROP, LOS, or NEC. Conclusion Analysis of early HR-SpO 2 characteristics adds to clinical risk factors to predict later adverse outcomes in VLBW infants.
enterocolitis (NEC). In this study, we hypothesized that analysis of HR and SpO 2 using pulse oximetry data from the first week after birth could improve prediction of later adverse outcomes when compared with analysis of clinical variables alone. This is a fundamentally different concept than using such data for early detection of deterioration. Rather, the goal is to identify infants at high risk of morbidity later in their course to direct care toward mitigating or preventing disease. Thus, the objectives of this study were to develop and validate multivariable predictive models that combine pulse oximetry data and clinical data to predict risk of death and other adverse neonatal outcomes in a two-center cohort of VLBW infants.
Methods

Patient Population
The Institutional Review Boards at the University of Virginia (UVA) and Columbia University (CU) approved this study with waiver of consent. We included all VLBW (< 1,500 g at birth) infants admitted to the UVA NICU from 2009 to 2015 and to the CU NICU from 2012 to 2015 with at least 1 hour of pulse oximetry data available within 12 hours of birth. Infants with cyanotic congenital heart defects and infants provided comfort care only from birth were excluded.
Medical records were reviewed to determine the occurrence of death prior to NICU discharge, severe intraventricular hemorrhage (sIVH) (grades III-IV), LOS (clinical sepsis after 3 days of age with a positive blood culture and at least 5 days antibiotics), NEC (Bell's stages 2-3), BPD (receiving supplemental oxygen at 36 weeks' PMA), and severe retinopathy of prematurity (ROP) treated with laser or bevacizumab therapy (treated ROP [tROP]).
Pulse Oximetry Monitoring
HR and SpO 2 data were collected every 2 seconds (0.5 Hz) from all infants using Masimo pulse oximeters (Masimo Corporation, Irvine, CA) with 8 seconds SpO 2 averaging time. These devices use signal extraction technology for high accuracy during patient movement and low perfusion by separating the pulsatile arterial signal from other signals created by motion. 6 Data at both centers are continuously stored for review using BedMasterEx (Excel Medical, Jupiter, FL) data transfer system.
Clinical Predictive Score
Baseline risk of adverse outcomes was analyzed by developing a clinical predictive score from variables available at the time of birth that are known to impact risk of adverse outcomes. Clinical data included in the score were birth weight (BW), GA, sex, antenatal steroid exposure (at least one dose) and 1 and 5 minutes Apgar scores. Differences among sites were also considered by including a binary variable for NICU 1 versus NICU 2. Each outcome was used to fit a multivariate logistic regression model including these variables. All available pulse oximetry data from both the first 12 hours and first 7 days after birth were used to calculate the mean, SD, kurtosis and skewness of HR and SpO 2 , and the maximum and minimum cross-correlation of HR and SpO 2 over each of these time periods. At least 6 hours of data within 12 hours of birth were required to be included in the analysis.
Pulse oximetry measures used in the models were chosen as descriptive summary statistics for a time series dataset. Mean, SD, skewness, and kurtosis all describe the shape of the distribution of HR and SpO 2 values, sampled every 2 seconds, during the defined time periods. Skewness is a measure of symmetry of a dataset and kurtosis is a measure of the shape of a data distribution compared with a normal distribution. The kurtosis of a normal distribution is 3, and variables with kurtosis higher than this will have more extreme outliers.
The cross-correlation of two variables is a measure of the degree to which they trend together, either in the same or opposite directions, within a set lag time of each other. For this study, cross-correlation of HR and SpO 2 was calculated over 10-minute windows using the Matlab function XCORR with a lag time of À30 to þ30 seconds. 5 A high crosscorrelation indicates the two signals are in positive synchrony and a negative or low cross-correlation indicates the two signals travel in synchrony in opposite directions. We used the maximum and minimum cross-correlation HRSpO 2 values in the first 12 hours or 7 days after birth in the multivariate models for each outcome. A predictive score using pulse oximetry measures alone was developed for each outcome to fit a multivariate logistic regression model. Measures from the first 12 hours after birth were used in the models to predict risk of death and sIVH, while data from the first 7 days after birth were used in the models for risk of LOS, NEC, BPD, and tROP. These time frames were chosen based on pathophysiology of the targeted outcomes and testing of multiple time periods to optimize the predictive model. Other time periods tested were 3 and 24 hours and 3 days after birth.
Pulse Oximetry Predictive Score
Pulse oximetry predictive score (POPS) was calculated for each outcome for each infant using a bivariate logistic regression model to combine the model using pulse oximetry measures alone with the clinical predictive score. The individual models were converted to units of log odds with the logit function prior to training the model. To ensure highquality results, we used the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) statement checklist for our approach to analyzing and reporting this study.
Validation
Bootstrapping was used to calculate confidence intervals and p-values of the area under the receiver-operating characteristic curve (AUC) for all predictive models (TRIPOD type 1b prediction model study). In addition, models were validated by training models on each NICU and externally validating on the other NICU (TRIPOD type 3 prediction model study). Bootstrapping was used here as well to calculate standard errors and confidence intervals for AUC estimates and calculate p-values for test of whether performance differed between sites.
Statistical Analysis
The AUC of each model was calculated to determine the predictive performance of the clinical predictive score, pulse oximetry score, and POPS for each outcome. The p-values on the coefficient were used to test the hypothesis of significance of each model when corrected for the other and to quantify added value.
The added value of POPS over the predictive model using clinical variables alone was also quantified by calculating a net reclassification improvement (NRI), 8 a measure of the sum of proportions of patients reclassified into the correct risk group by one risk marker compared with another. NRI serves to quantify the relative accuracy of a new test or marker in comparison with an established test or marker. In this study, we used a continuous NRI calculation method since the predictive scores compared are not categorical.
9
Statistical analyses were performed in MATLAB (MathWorks, INC, Natick, MA) and in GraphPad Prism 7 (GraphPad Software, Inc., San Diego, CA) with two-tailed p-values <0.05 considered significant.
Results
Patient Population
Of 1,023 inborn VLBW infants, 778 met inclusion criteria (►Table 1). Of those excluded, 44 had congenital anomalies or received comfort care only and 201 had insufficient pulse oximetry data available. The rates of each outcome were compared between the two NICUs using Fisher's exact test and were significantly different for BPD, tROP, and NEC but not for death, sIVH, and LOS (►Table 1). The average age at death was 31 AE 19 days and age at diagnosis of LOS or NEC was 28 AE 14 days. Mean GA was significantly higher by 0.5 weeks for infants at NICU 2, but there was no significant difference in BW. Twenty percent of infants in the combined cohort were small for GA (24% at NICU 2 and 18% at NICU 1) as determined using the 10th percentile of Fenton growth charts for premature male and female infants. Maternal race was predominantly Caucasian in the NICU 1 cohort (65%), while NICU 2 mothers were more ethnically and racially diverse. The mode of delivery was by cesarean section for 65% of infants in the combined cohort with no significant difference between the two sites.
Predictive Models
For the first 12 hours after birth, the mean number of hours of pulse oximetry data available for analysis per infant was 10 hours and for the first 6 and 7 days. Pulse oximetry measures were averaged and compared for infants with or without each outcome (►Table 2). The significance and relative rank of variable coefficients in the multivariate logistic regression models used to calculate the clinical and physiologic risk scores are shown in ►Table 3. In the model using pulse oximetry measures alone, the pulse rate SD was the overall highest ranking variable of all outcomes combined, followed by HR skewness. GA was highest ranking overall for the clinical variables predictive score, followed by site.
Predictive Model Performance
Both clinical and pulse oximetry scores modeled using the two-center cohort demonstrated high predictive performance by AUC for all outcomes (►Table 4). The AUCs were highest when clinical and pulse oximetry models were combined to calculate a POPS for each outcome. POPS predicted all adverse outcomes (p 0.05), but the predictive performance was most significant for the outcomes of death and BPD. Analysis using NRI showed that pulse oximetry data improved risk prediction over clinical data alone for death, sIVH, and BPD, but not for tROP, LOS, or NEC. Plotting POPS versus the clinical predictive score (►Fig. 1) in cases and controls illustrates the net proportion of infants correctly reclassified as high risk or low risk by adding pulse oximetry data to the predictive model. Visually, this is represented by the proportion of cases in the left upper quadrant and of controls in the right lower quadrant of each graph. Quadrants are divided by dotted lines drawn at the score on the x and y axes above which the number of patients equals the incidence of that outcome.
Cross-validation
We validated POPS using NICU 1 as a training dataset and NICU 2 as the test dataset and then reversed the process.
Performance was similar between test and training site when using NICU 1 as the development cohort and NICU 2 as the validation cohort. However, performance varied for several outcomes with NICU 2 set as the development cohort and NICU 1 as the validation cohort (►Table 5).
Discussion
In this two-center study of VLBW infants, we found that analysis of early cardiorespiratory pulse oximetry data adds information to clinical data for prediction of death and adverse outcomes, particularly severe IVH and BPD. We developed a POPS that uses analysis of HR and SpO 2 in addition to several clinical variables known to be associated with adverse outcomes and available at the time of birth. While POPS performed well for predicting late-onset sepsis, NEC, and severe ROP, our analysis suggests the most important variables in the first week for predicting these outcomes are demographic. We found that site affected model performance, but to a relatively small degree, even though the sites had very different rates of the outcome events. One major premise for our approach is that abnormal cardiorespiratory dynamics early after VLBW birth denote vulnerability to subsequent adverse outcomes. Established scores such as the Apgar score, PhysiScore, 2 and Score for Neonatal Acute Physiology, 3 which are measured in the first 10 minutes, 3, and 24 hours, respectively, after birth, identify infants at increased risk of death and morbidity. All take into Abbreviations: BPD, bronchopulmonary dysplasia; HR, heart rate; LOS, late-onset septicemia; NEC, necrotizing enterocolitis; sIVH, severe intraventricular hemorrhage; SpO account, with different degrees of mathematical sophistication, cardiorespiratory status. A different kind of predictive measure, the HRC index, was developed by our group and is a continuously updated risk of sepsis based on the finding of decreased HR variability and transient HR decelerations. The average first day HRC index also reports on risk of death and IVH and average first week value on risk of later sepsis or BPD diagnosis but not NEC or severe ROP.
1
A second premise is that evaluation of the interaction of the heart and lungs holds information about cardiorespiratory control that isolated analysis of each system lacks. This is affirmed by recent findings about changes in the cross- correlation of vital signs preceding sepsis and NEC. Fairchild et al recently published a study of cross-correlation of HR, SpO 2 , and respiratory rate in >1,000 VLBW infants and found that cross-correlation of HR and SpO 2 increases during the 24-hour period prior to clinical diagnosis of sepsis or NEC.
5
Some increase in cross-correlation of HR and SpO 2 is attributable to bradycardia and desaturation occurring with apnea, but it is seen even when infants are mechanically ventilated.
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In the current analysis, we combined these ideas: first, cardiorespiratory analysis soon after birth can help identify patients at risk for later morbidity and mortality and second, cardiorespiratory analysis should include the degree of interaction of the heart and lungs. Variables selected for POPS include measures that describe the shape of the histograms for HR and SpO 2 as well as the interaction between these two important vital signs that both can be measured by pulse oximetry alone. Our Table 5 Cross-validation of the pulse oximetry predictive score 
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In multivariate analysis, mean SpO 2 , a measure of overall oxygenation, was highly associated with death when calculated over the first 12 hours and with BPD when calculated over the first 7 days. For BPD, this relationship likely reflects more severe respiratory distress syndrome, but also warrants study as a target for interventions to improve SpO 2 targeting during this period. While data on FiO 2 were not available for this analysis, we assume they would not have changed the results given similar prescribed SpO 2 targets in the two units. Still, future studies should evaluate this assumption as more units acquire capability to collect and analyze FiO 2 data. High SpO 2 variability as measured by SD SpO 2 was also associated with risk of BPD and ranked highly in the multivariate vital sign risk model, which likely indicates that swings from hypoxemia to hyperoxemia are important as well. Our analysis did not consider position of the pulse oximetry sensor relative to the ductus arteriosus or its patency. We assumed that variation in sensor position was not related to outcome and if anything would decrease the strength of the association between SpO 2 patterns and outcomes. Measures of oxygenation did not add information to severe ROP prediction, despite their implication in the pathophysiology of this condition. In this and our previous study using early HRC to predict later outcomes, GA and BW were so highly correlated with severe ROP that models using these variables alone left little room for improvement from physiologic data.
There were several differences between patient populations at the institutions involved in this study. Most notably, there were large differences in rates of BPD and treated severe ROP. These differences likely reflect dissimilarities in population demographics, variations in practice, and illness severity. However, the performance of POPS developed at either center and tested at the other was not dramatically different. At both centers, pulse oximetry data analysis added significantly for BPD prediction and added little above clinical risk factors for severe ROP prediction. This suggests that these findings are likely to hold true at other NICUs. A study conducted at multiple NICUs in the NICHD Neonatal Network developed a model for BPD using demographic and clinical variables together with FiO 2 at multiple points in the first 28 days after birth, and showed that the weight of individual model components changed over time. 12 The model was developed and externally validated in cohorts that differed somewhat in demographics and BPD rates and performance was lower in the validation cohort. Further optimization and validation in prospective and additional NICU cohorts are needed to determine whether POPS can be applied broadly for risk adjustment between centers. Methods other than logistic regression might improve model performance. Several recent publications use detrended fluctuation analysis of vital signs to predict IVH. [13] [14] [15] It is important to note that IVH prediction has its limitations in retrospective studies such as ours due to the fact that the exact timing of the event is unknown. Abnormal HR and SpO 2 patterns in the first 12 hours after birth can represent disturbances caused by the hemorrhage rather than a warning of the event occurring later. Future work should test machine learning techniques in addition to more sophisticated regression analyses to predict both imminent and remote outcomes. Nonetheless, logistic regression is an appropriate first step for this type of analysis and performed well within and between centers. Partnership with bioengineering or software developers could allow an algorithm such as POPS to be built in to pulse oximetry monitoring and thus available for use in clinical care. At the bedside, POPS could potentially improve outcomes through targeted therapies or preventative strategies for infants marked high risk by abnormal physiologic patterns in addition to standard clinical risk factors. POPS could also help risk stratify patients within populations for research.
Conclusion
While demographic and clinical variables can be used to predict adverse outcomes in preterm infants, physiologic data improve outcome prediction by adding information on illness severity. In this study, we developed POPS, a tool that uses pulse oximetry and clinical data to predict adverse outcomes in VLBW infants in the first 12 hours or first week after birth. We also showed that adding HR and SpO 2 analysis to clinical data improved prediction of death, severe intraventricular hemorrhage, and bronchopulmonary dysplasia over clinical factors alone. Early identification of highrisk infants gives clinicians an opportunity to target specific populations or individual patients for preventative interventions or new treatments.
